vs
Apellis Pharmaceuticals, Inc.（APLS）与Cable One, Inc.（CABO）财务数据对比。点击上方公司名可切换其他公司
Cable One, Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.8倍（$363.7M vs $199.9M），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -6.1%），Cable One, Inc.自由现金流更多（$71.6M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -5.2%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Cable One, Inc.是美国一家宽带通信服务商，以Sparklight为品牌面向美国24个州的110万个人及商业客户提供有线电视、互联网与电话服务。该公司还拥有Fidelity Communications品牌，在阿肯色、路易斯安那、密苏里、俄克拉荷马与德克萨斯提供同类通信服务，其总部坐落于亚利桑那州凤凰城。
APLS vs CABO — 直观对比
营收规模更大
CABO
是对方的1.8倍
$199.9M
营收增速更快
APLS
高出0.1%
-6.1%
自由现金流更多
CABO
多$85.8M
$-14.3M
两年增速更快
APLS
近两年复合增速
-5.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $363.7M |
| 净利润 | $-59.0M | — |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 25.2% |
| 净利率 | -29.5% | — |
| 营收同比 | -5.9% | -6.1% |
| 净利润同比 | -62.2% | — |
| 每股收益（稀释后） | $-0.40 | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSCABO
| Q4 25 | $199.9M | $363.7M | ||
| Q3 25 | $458.6M | $376.0M | ||
| Q2 25 | $178.5M | $381.1M | ||
| Q1 25 | $166.8M | $380.6M | ||
| Q4 24 | $212.5M | $387.2M | ||
| Q3 24 | $196.8M | $393.6M | ||
| Q2 24 | $199.7M | $394.5M | ||
| Q1 24 | $172.3M | $404.3M |
净利润APLSCABO
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $86.5M | ||
| Q2 25 | $-42.2M | $-438.0M | ||
| Q1 25 | $-92.2M | $2.6M | ||
| Q4 24 | $-36.4M | — | ||
| Q3 24 | $-57.4M | $44.2M | ||
| Q2 24 | $-37.7M | $38.2M | ||
| Q1 24 | $-66.4M | $37.4M |
营业利润率APLSCABO
| Q4 25 | -25.6% | 25.2% | ||
| Q3 25 | 48.7% | 25.2% | ||
| Q2 25 | -18.6% | -128.4% | ||
| Q1 25 | -50.0% | 25.1% | ||
| Q4 24 | -12.3% | 26.2% | ||
| Q3 24 | -24.0% | 28.0% | ||
| Q2 24 | -14.7% | 27.9% | ||
| Q1 24 | -36.0% | 29.6% |
净利率APLSCABO
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | 23.0% | ||
| Q2 25 | -23.6% | -114.9% | ||
| Q1 25 | -55.3% | 0.7% | ||
| Q4 24 | -17.1% | — | ||
| Q3 24 | -29.2% | 11.2% | ||
| Q2 24 | -18.9% | 9.7% | ||
| Q1 24 | -38.5% | 9.2% |
每股收益（稀释后）APLSCABO
| Q4 25 | $-0.40 | $-0.49 | ||
| Q3 25 | $1.67 | $14.52 | ||
| Q2 25 | $-0.33 | $-77.70 | ||
| Q1 25 | $-0.74 | $0.46 | ||
| Q4 24 | $-0.30 | $-18.05 | ||
| Q3 24 | $-0.46 | $7.58 | ||
| Q2 24 | $-0.30 | $6.58 | ||
| Q1 24 | $-0.54 | $6.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $152.8M |
| 总债务越低越好 | — | $2.6B |
| 股东权益账面价值 | $370.1M | $1.4B |
| 总资产 | $1.1B | $5.6B |
| 负债/权益比越低杠杆越低 | — | 1.81× |
8季度趋势，按日历期对齐
现金及短期投资APLSCABO
| Q4 25 | $466.2M | $152.8M | ||
| Q3 25 | $479.2M | $166.6M | ||
| Q2 25 | $370.0M | $152.9M | ||
| Q1 25 | $358.4M | $149.1M | ||
| Q4 24 | $411.3M | $153.6M | ||
| Q3 24 | $396.9M | $226.6M | ||
| Q2 24 | $360.1M | $201.5M | ||
| Q1 24 | $325.9M | $210.7M |
总债务APLSCABO
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | — | $3.6B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | — | $3.5B | ||
| Q1 24 | $93.1M | $3.6B |
股东权益APLSCABO
| Q4 25 | $370.1M | $1.4B | ||
| Q3 25 | $401.2M | $1.4B | ||
| Q2 25 | $156.3M | $1.3B | ||
| Q1 25 | $164.2M | $1.8B | ||
| Q4 24 | $228.5M | $1.8B | ||
| Q3 24 | $237.1M | $1.9B | ||
| Q2 24 | $264.3M | $1.9B | ||
| Q1 24 | $266.7M | $1.9B |
总资产APLSCABO
| Q4 25 | $1.1B | $5.6B | ||
| Q3 25 | $1.1B | $5.7B | ||
| Q2 25 | $821.4M | $5.8B | ||
| Q1 25 | $807.3M | $6.4B | ||
| Q4 24 | $885.1M | $6.5B | ||
| Q3 24 | $901.9M | $6.7B | ||
| Q2 24 | $904.5M | $6.7B | ||
| Q1 24 | $831.9M | $6.7B |
负债/权益比APLSCABO
| Q4 25 | — | 1.81× | ||
| Q3 25 | — | 1.88× | ||
| Q2 25 | — | 2.16× | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 1.84× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | 0.35× | 1.93× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $145.5M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $71.6M |
| 自由现金流率自由现金流/营收 | -7.1% | 19.7% |
| 资本支出强度资本支出/营收 | 0.1% | 20.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $278.1M |
8季度趋势，按日历期对齐
经营现金流APLSCABO
| Q4 25 | $-14.2M | $145.5M | ||
| Q3 25 | $108.5M | $156.5M | ||
| Q2 25 | $4.4M | $144.9M | ||
| Q1 25 | $-53.4M | $116.3M | ||
| Q4 24 | $19.4M | $167.6M | ||
| Q3 24 | $34.1M | $176.2M | ||
| Q2 24 | $-8.3M | $155.5M | ||
| Q1 24 | $-133.0M | $164.8M |
自由现金流APLSCABO
| Q4 25 | $-14.3M | $71.6M | ||
| Q3 25 | $108.3M | $84.8M | ||
| Q2 25 | $4.4M | $76.6M | ||
| Q1 25 | $-53.4M | $45.2M | ||
| Q4 24 | $19.3M | $95.7M | ||
| Q3 24 | — | $99.2M | ||
| Q2 24 | $-8.4M | $84.0M | ||
| Q1 24 | $-133.3M | $98.9M |
自由现金流率APLSCABO
| Q4 25 | -7.1% | 19.7% | ||
| Q3 25 | 23.6% | 22.5% | ||
| Q2 25 | 2.5% | 20.1% | ||
| Q1 25 | -32.0% | 11.9% | ||
| Q4 24 | 9.1% | 24.7% | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | -4.2% | 21.3% | ||
| Q1 24 | -77.3% | 24.5% |
资本支出强度APLSCABO
| Q4 25 | 0.1% | 20.3% | ||
| Q3 25 | 0.0% | 19.1% | ||
| Q2 25 | 0.0% | 17.9% | ||
| Q1 25 | 0.0% | 18.7% | ||
| Q4 24 | 0.0% | 18.6% | ||
| Q3 24 | 0.0% | 19.6% | ||
| Q2 24 | 0.0% | 18.1% | ||
| Q1 24 | 0.2% | 16.3% |
现金转化率APLSCABO
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 1.81× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 44.62× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.99× | ||
| Q2 24 | — | 4.08× | ||
| Q1 24 | — | 4.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
CABO
暂无分部数据
